BIO RAD LABS INC - CL B (BIOB)

Historical Holders from Q1 2014 to Q3 2025

Symbol
BIOB on NYSE
Type / Class
Equity / CL B
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,894
Holdings value
$809,486
% of all portfolios
0%
Number of holders
5
Number of buys
1
Number of sells
-1
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BIO RAD LABS INC - CL B (BIOB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2,894 $809,486 +$207,881 $282.98 5
2025 Q2 2,137 $520,406 +$477 $242.29 5
2025 Q1 2,135 $518,363 -$360,172 $241.99 5
2024 Q4 3,309 $1,077,595 -$7,561 $325.59 8
2024 Q3 3,332 $1,106,901 +$213,193 $331.91 6
2024 Q2 3,445 $935,111 -$57,483 $273.69 8
2024 Q1 3,656 $1,251,367 +$10,084 $340.63 7
2023 Q4 3,627 $1,162,875 -$704,377 $318.43 6
2023 Q3 5,613 $1,999,599 +$711 $355.06 8
2023 Q2 5,611 $2,104,573 -$164,829 $376.06 7
2023 Q1 5,934 $2,754,171 +$190,910 $464.21 9
2022 Q4 3,636 $1,512,290 +$184,869 $412 8
2022 Q3 5,295 $2,218,000 -$187,000 $417.3 7
2022 Q2 5,662 $2,749,000 +$259,466 $493.62 8
2022 Q1 5,023 $2,878,000 -$77,563,998 $564 7
2021 Q4 109,107 $82,364,000 -$898,882 $755.18 12
2021 Q3 110,301 $82,303,864 +$501,162 $743.16 12
2021 Q2 109,626 $70,615,000 +$59,486,174 $641.19 10
2021 Q1 17,973 $10,338,000 +$3,819,863 $571.27 10
2020 Q4 11,373 $6,604,000 -$3,833,066 $582.64 6
2020 Q3 17,989 $9,242,000 +$269,983 $509.8 7
2020 Q2 17,459 $7,840,000 +$525,556 $448.96 6
2020 Q1 16,266 $5,703,000 -$831,233 $351.01 6
2019 Q4 18,390 $6,798,000 -$2,975,648 $369.95 8
2019 Q3 26,573 $9,045,588 +$48,397 $339.9 8
2019 Q2 26,422 $8,202,000 +$163,000 $311.21 6
2019 Q1 25,905 $7,856,000 -$199,729 $304.58 6
2018 Q4 26,693 $6,140,000 -$2,065,035 $230 7
2018 Q3 32,768 $10,238,000 +$341,007 $312.73 7
2018 Q2 31,672 $9,136,000 +$27,788 $286.51 5
2018 Q1 31,580 $7,921,000 +$108,851 $250.28 6
2017 Q4 31,144 $7,546,000 +$180 $238.21 6
2017 Q3 31,144 $7,027,000 -$956,324 $223.34 6
2017 Q2 36,044 $8,111,000 +$1,380,025 $225.01 5
2017 Q1 29,910 $5,977,000 -$5,000 $199.88 5
2016 Q4 29,937 $5,479,000 +$73,545 $182.67 6
2016 Q3 29,538 $4,791,000 -$16,582 $162.38 4
2016 Q2 29,641 $4,208,000 -$34,674 $141.93 4
2016 Q1 29,884 $4,036,000 -$29,667 $135.03 5
2015 Q4 30,119 $4,156,000 +$21,773 $137.97 4
2015 Q3 29,958 $4,070,000 -$193,377 $134.45 5
2015 Q2 31,267 $4,584,000 +$206,861 $146.5 6
2015 Q1 29,855 $4,032,485 +$49,422 $135 4
2014 Q4 29,500 $3,554,325 -$10,795,640 $120.24 6
2014 Q3 124,933 $14,105,000 +$16,074 $114.31 8
2014 Q2 124,761 $15,043,000 +$11,374,096 $123.29 7
2014 Q1 29,743 $3,794,000 +$37,567 $127.94 6